Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

This report aims to provide a comprehensive study of the global market for exosome diagnostic, therapeutic, and research tools, both in terms of quantitative and qualitative data, to help readers develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding exosome products. The publisher estimates market data for 2022 (the base year) and forecasts values for 2023 through 2028.

The scope of this study is global and covers exosome products and research tools used in the healthcare industry only. Exosome products and research tools used in other sectors, such as skincare and beauty, are beyond the scope of this report.

Report Includes

• 14 data tables and 77 additional tables
• Analysis of the global markets and global trends for exosome diagnostics and therapeutics, with revenue data for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028
• Estimate of the current market size and revenue growth prospects, along with a market share analysis based on product, application, end user and region
• Facts and figures pertaining to the market drivers, opportunities and restraints, and the impacts of macroeconomic variables
• Discussion of emerging technologies, regulations and R&D efforts
• Evaluation of new commercial opportunities in the diagnostics, therapeutics and research tools markets, and an assessment of trends, products and assay developments
• Insight into the use of exosome proteins and nucleic acids as diagnostic biomarkers and their impact on the microRNA, liquid biopsy and stem cell research industry
• Analysis of relevant patents related to exosome diagnostics and therapeutics in the U.S., Europe and Japan
• Overview of sustainability trends and ESG developments, including consumer attitudes, companies’ ESG score rankings and their ESG practices
• Analysis of the competitive landscape, including companies’ market shares, business segments, financials and product portfolios, as well as recent M&A activity and a venture funding outlook
• Company profiles of major players within the industry, including Bio-Techne, Exosomics S.p.A., and System Biosciences LLC.